211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome | MicrobiomeTrials
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2019-07-10Est. Completion: 2028-01-28
Enrollment target: 30 participants
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States